Barclays

Barclays’s Cullinan Oncology CGEM Stock Holding History

Barclays’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.99M	Sell	140,295 -129,360	-48%	-$1.66M	﹤0.01%	2356
2025 Q4	$2.79M	Buy	269,655 +18,545	+7%	+$167K	﹤0.01%	2682
2025 Q3	$1.49M	Sell	251,110 -17,357	-6%	-$127K	﹤0.01%	3107
2025 Q2	$2.02M	Buy	268,467 +27,124	+11%	+$218K	﹤0.01%	2837
2025 Q1	$1.83M	Sell	241,343 -3,888	-2%	-$37.3K	﹤0.01%	2699
2024 Q4	$2.99M	Sell	245,231 -3,383	-1%	-$48.6K	﹤0.01%	2591
2024 Q3	$4.16M	Buy	248,614 +51,300	+26%	+$910K	﹤0.01%	2249
2024 Q2	$3.44M	Buy	197,314 +157,122	+391%	+$3.35M	﹤0.01%	1766
2024 Q1	$685K	Sell	40,192 -45,032	-53%	-$696K	﹤0.01%	3388
2023 Q4	$868K	Buy	85,224 +31,831	+60%	+$282K	﹤0.01%	3542
2023 Q3	$483K	Buy	53,393 +31,650	+146%	+$330K	﹤0.01%	2829
2023 Q2	$234K	Sell	21,743 -6,570	-23%	-$69.8K	﹤0.01%	3170
2023 Q1	$290K	Buy	28,313 +6,817	+32%	+$75.2K	﹤0.01%	3595
2022 Q4	$227K	Buy	21,496 +12,502	+139%	+$152K	﹤0.01%	3771
2022 Q3	$116K	Buy	8,994 +1,731	+24%	+$23.3K	﹤0.01%	3479
2022 Q2	$93K	Sell	7,263 -65	-0.9%	-$737	﹤0.01%	3793
2022 Q1	$77K	Buy	+7,328	New	+$99K	﹤0.01%	3909

Other funds holding CGEM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Kynam Capital Management Princeton, New Jersey $1.58B AUM 138.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Blue Owl Capital Holdings New York $369M AUM 78.25% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return